CIPLA:NSE
Cipla Ltd
₹1,315.00
arrow_downward
-0.92%(-12.20) 1D
Okt 8, 11:12:04 AM GMT+5:30 · INR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa CIPLA...
Buksan
₹1,323.20
Mataas
₹1,334.20
Mababa
₹1,313.00
Mkt. cap
1.06T
Avg. na dami
919.04K
Dami
111.19K
Dividend
0.99%
Bawat tatlong buwang dividend
₹3.25
Petsa ng ex-dividend
Hun 5, 2026
P/E ratio
31.53
Mataas nang 52-wk
₹1,673.00
Mababa nang 52-wk
₹1,165.70
EPS
₹41.70
Mga natitirang share
805.67M
Bilang ng mga empleyado
31K
Buksan
₹1,323.20
Mataas
₹1,334.20
Mababa
₹1,313.00
Mkt. cap
1.06T
Avg. na dami
919.04K
Dami
111.19K
Dividend
0.99%
Bawat tatlong buwang dividend
₹3.25
Petsa ng ex-dividend
Hun 5, 2026
P/E ratio
31.53
Mataas nang 52-wk
₹1,673.00
Mababa nang 52-wk
₹1,165.70
EPS
₹41.70
Mga natitirang share
805.67M
Bilang ng mga empleyado
31K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
investingLive
·
17 oras ang nakalipas
The S&P 500 reached a new record high, but the gains are vulnerable to a sharp reversal
Investor's Business Daily
·
1 buwan ang nakalipas
Dow Jones Futures: Techs Set To Run? Nvidia, CrowdStrike, Okta, Salesforce Jump On Earnings
Reuters
·
1 buwan ang nakalipas
S&P 500 to end 2026 slightly above current levels on profit optimism
CNBC
·
1 buwan ang nakalipas
Equal-weight S&P 500 is leading the 2026 market and its flagship trade just hit $100 billion
Profile
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
Tungkol sa Cipla Ltd
CEOUmang Vohra
Mga Empleyado31.4K
Itinatag1935
HeadquartersMumbai, Maharashtra, India
Sektor-
Websitecipla.com